Cloning the Recipient Vector to Include a Tissue-specific Promoter
3:48
Cloning the Sponge
4:55
Generation of Stable H9c2 miR-181-sponge Expressing Cells
5:53
Synthesis and Purification of Sponge-nanoparticles (miR-181-sponge Nanoparticles)
7:01
Results: Validation of Nanonvector Delivery of the miR-181-sponge and its Effect on miR-181c Expression
7:58
Conclusion
Transcript
So for the last couple of decades, the importance of microRNA has been recognized in human disease conditions, but the problem is that, therapy-wise, it did not go to the primetime. One of the problem is, one microRNA can have different targets in
Sign in or start your free trial to access this content
Væv-specifikke microRNA hæmning er en teknologi, der er underudviklede i feltet microRNA. Heri, beskriver vi en protokol for at kunne hæmme familien miR-181 microRNA i myoblast celler fra hjertet. Nanovector teknologi bruges til at levere en mikroRNA svamp, der viser betydelig i vivo cardio-specifikke miR-181 familie hæmning.